High fat diet-induced animal model of age-associated obesity and osteoporosis

Journal of Nutritional Biochemistry

Volumn 21, Issue 12, 2010, Pages 1162-1169

  Halade, Ganesh V ^a   Rahman, Md M ^a   Williams, Paul J ^a   Fernandes, Gabriel ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adipocytes; Animal model; Bone adiposity; Fat mass; Obesity; Osteoporosis; Proinflammatory cytokines

Indexed keywords

CATHEPSIN K; CORN OIL; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL FAT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE DENSITY; EXPERIMENTAL MOUSE; FEMALE; GENE EXPRESSION; LIPID DIET; MOUSE; NONHUMAN; OBESITY; POSTMENOPAUSE OSTEOPOROSIS; RECEPTOR UPREGULATION;

ADIPOCYTES; ANIMALS; BODY WEIGHT; BONE DENSITY; CATHEPSIN K; CELLS, CULTURED; CORN OIL; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; OBESITY; OSTEOPOROSIS; PPAR GAMMA; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

ANIMALIA; MUS; RODENTIA; ZEA MAYS;

EID: 78249259079     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.10.002     Document Type: Article

References (56)

1. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2:35-43.
2. Zhao L.J., Jiang H., Papasian C.J., et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 2008, 23:17-29.
3. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
4. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.
5. Nelson-Dooley C., Della-Fera M.A., Hamrick M., Baile C.A. Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes. Curr Med Chem 2005, 12:2215-2225.
6. Batsis J.A., Nieto-Martinez R.E., Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 2007, 82:509-524.
7. Lorenzo C., Serrano-Rios M., Martinez-Larrad M.T., et al. Which obesity index best explains prevalence differences in type 2 diabetes mellitus?. Obesity (Silver Spring) 2007, 15:1294-1301.
8. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J Cell Biochem 2006, 98:251-266.
9. Rodriguez J.P., Astudillo P., Rios S., Pino A.M. Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther 2008, 3:208-218.
10. Manolagas S.C., Jilka R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995, 332:305-311.
11. Vost A. Osteoporosis: a necropsy study of vertebrae and iliac crests. Am J Pathol 1963, 43:143-151.
12. Hartsock R.J., Smith E.B., Petty C.S. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. A study made from 177 cases of sudden death examined by necropsy. Am J Clin Pathol 1965, 43:326-331.
13. Miller M.E., Kral J.G. Surgery for obesity in older women. Menopause Int 2008, 14:155-162.
14. Nunez N.P., Carpenter C.L., Perkins S.N., et al. Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity (Silver Spring) 2007, 15:1980-1987.
15. James P.T., Leach R., Kalamara E., Shayeghi M. The worldwide obesity epidemic. Obes Res 2001, 9(Suppl 4):228S-233S.
16. Hagey A.R., Warren M.P. Role of exercise and nutrition in menopause. Clin Obstet Gynecol 2008, 51:627-641.
17. Buettner R., Scholmerich J., Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007, 15:798-808.
18. Turner R.T., Vandersteenhoven J.J., Bell N.H. The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 1987, 2:115-122.
19. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991, 15:175-191.
20. Bateman T.A., Dunstan C.R., Ferguson V.L., Lacey D.L., Ayers R.A., Simske S.J. Osteoprotegerin mitigates tail suspension-induced osteopenia. Bone 2000, 26:443-449.
21. Bateman T.A., Dunstan C.R., Lacey D.L., Ferguson V.L., Ayers R.A., Simske S.J. Osteoprotegerin ameliorates sciatic nerve crush induced bone loss. J Orthop Res 2001, 19:518-523.
22. Amar S., Zhou Q., Shaik-Dasthagirisaheb Y., Leeman S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci USA 2007, 104:20466-20471.
23. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., Feinglos M.N., Diet-induced type I.I. diabetes in C57BL/6J mice. Diabetes 1988, 37:1163-1167.
24. Simopoulos A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002, 56:365-379.
25. Sun D., Krishnan A., Zaman K., Lawrence R., Bhattacharya A., Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003, 18:1206-1216.
26. Nagy T.R., Clair A.L. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 2000, 8:392-398.
27. Rahman M., Halade G.V., El Jamali A., Fernandes G. Conjugated linoleic acid (CLA) prevents age-associated skeletal muscle loss. Biochem Biophys Res Commun 2009, 383:513-518.
28. Bhattacharya A., Rahman M., Sun D., Fernandes G. Effect of fish oil on bone mineral density in aging C57BL/6 female mice. J Nutr Biochem 2007, 18:372-379.
29. Hiraga T., Williams P.J., Ueda A., Tamura D., Yoneda T. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 2004, 10:4559-4567.
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
31. Wallace T.M., Levy J.C., Matthews D.R. An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Diabet Med 2004, 21:568-576.
32. Perseghin G., Caumo A., Caloni M., Testolin G., Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 2001, 86:4776-4781.
33. Glatt V., Canalis E., Stadmeyer L., Bouxsein M.L. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 2007, 22:1197-1207.
34. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
35. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
36. Chen J.L., Hunt P., McElvain M., Black T., Kaufman S., Choi E.S. Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 1997, 15:368-377.
37. Cheleuitte D., Mizuno S., Glowacki J. In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. J Clin Endocrinol Metab 1998, 83:2043-2051.
38. Crepaldi G., Romanato G., Tonin P., Maggi S. Osteoporosis and body composition. J Endocrinol Invest 2007, 30:42-47.
39. Zhao L.J., Liu Y.J., Liu P.Y., Hamilton J., Recker R.R., Deng H.W. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007, 92:1640-1646.
40. Rasouli N., Kern P.A. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008, 93:S64-S73.
41. Akune T., Ohba S., Kamekura S., et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004, 113:846-855.
42. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol Rev 1998, 78:783-809.
43. Funicello M., Novelli M., Ragni M., et al. Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores. PLoS ONE 2007, 2:e683.
44. Chiellini C., Costa M., Novelli S.E., et al. Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol 2003, 195:309-321.
45. Saftig P., Hunziker E., Wehmeyer O., et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A 1998, 95:13453-13458.
46. Kyung T.W., Lee J.E., Phan T.V., Yu R., Choi H.S. Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice. J Nutr 2009, 139:502-506.
47. Stoch S.A., Wagner J.A. Cathepsin K inhibitors: a novel target for osteoporosis therapy. Clin Pharmacol Ther 2008, 83:172-176.
48. Gimble J.M., Robinson C.E., Wu X., et al. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 1996, 50:1087-1094.
49. Huang J.T., Welch J.S., Ricote M., et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382.
50. Lecka-Czernik B., Moerman E.J., Grant D.F., Lehmann J.M., Manolagas S.C., Jilka R.L. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002, 143:2376-2384.
51. Kirkland J.L., Tchkonia T., Pirtskhalava T., Han J., Karagiannides I. Adipogenesis and aging: does aging make fat go MAD?. Exp Gerontol 2002, 37:757-767.
52. Hotta K., Bodkin N.L., Gustafson T.A., Yoshioka S., Ortmeyer H.K., Hansen B.C. Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. J Gerontol A Biol Sci Med Sci 1999, 54:B183-B188.
53. Brooks E.R., Heltz D., Wozniak P., Partington C., Lovejoy J.C. Lateral spine densitometry in obese women. Calcif Tissue Int 1998, 63:173-176.
54. Fernandez-Real J.M., Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003, 24:278-301.
55. Kitaura H., Sands M.S., Aya K., et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol 2004, 173:4838-4846.
56. Rodan G.A. Introduction to bone biology. Bone 1992, 13(Suppl 1):S3-S6.